Skip to main content
    M

    MetLife Inc (MET)

    Official site

    FINANCIAL SERVICES • INSURANCE - LIFE • NYSE

    $101.45
    -1.20 (-1.16%)

    Market Cap: $64.51B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    MetLife Inc (MET) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    MetLife (MET) trades at 10.0x trailing earnings and 0.8x sales. Its P/E of 10.0x is above its 5-year median of 9.4x. Its forward P/E is 11.3x. The median P/E across 11 similar companies is 11.7x.

    Current Multiples

    Its forward P/E is above its trailing P/E, which implies earnings per share about 11.5% lower over the next year.

    MultipleValue
    P/E (trailing)10.0x
    Forward P/E11.3x
    Price to sales0.8x
    Price to book2.9x
    EV/EBITDA12.7x
    PEG0.5
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 9.9% above 9.1x, its P/S is in line and its P/B is 222.2% above 0.9x.

    MultipleCurrent5-year median10-year median
    P/E10.0x9.4x9.1x
    P/S0.8x0.8x0.8x
    P/B2.9x1.8x0.9x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 6.9x in 2021 to 11.7x in 2016.

    Year endPriceP/EP/SP/B
    2025$78.949.0x0.7x1.8x
    2024$81.8810.0x0.8x2.1x
    2023$66.139.1x0.7x1.6x
    2022$72.3710.6x0.8x1.9x
    2021$62.496.9x0.8x0.8x
    2020$46.957.6x0.6x0.6x
    2019$50.978.3x0.7x0.7x
    2018$41.067.6x0.6x0.8x
    2017$50.5611.4x0.9x0.9x
    2016$53.8911.7x1.0x0.9x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About MET

    What is MET's forward P/E ratio?

    MetLife has a forward P/E ratio of 11.3x.

    Is MET stock overvalued?

    GNG's valuation label for MET is Fairly valued. Its P/E of 10.0x compares with a median of 11.7x across 11 similar companies.

    What is MET's price to sales ratio?

    MetLife has a price to sales ratio of 0.8x.

    What is MetLife's average P/E ratio over 5 years?

    MetLife's median P/E over the last 5 years is 9.4x, from 60 month-end values through Oct 2026.

    What is MET's PEG ratio?

    MetLife has a PEG ratio of 0.5.